Recent Articles

Popular Posts

Site search

Follow Us

Second Annual Stem Cell Meeting

Written by on Wednesday, March 7th, 2007 Print This Post Print This Post

The Second Annual Stem Cell Meeting will be held on March 12-13, 2007 at the Mission Bay Conference Center at the University of California, San Francisco.  This event is the premier international event bringing together world-renowned scientists at the frontier of embryonic and adult stem cell research with decision makers and thought leaders in policy, ethics, patient advocacy, finance, business, and media to explore the challenge and promise of the research and the compelling potential of emerging therapies.  The speaker list includes:

  • Marc Beer
    President and CEO, ViaCell Inc.
  • Donald Berry
    Chair, Biostatistics, MD Anderson Cancer Research Center
  • G. Steven Burrill
    CEO, Burrill & Company
  • Bruce Cohen
    President and CEO, Cellerant Therapeutics, Inc.
  • Larry Goldstein
    Director, UCSD Stem Cell Institute
  • David Gollaher
    President and CEO,California Healthcare Institute
  • Zach W. Hall
    President and Chief Scientific Officer, CIRM
  • Marc H. Hedrick
    President, Cytori Therapeutics
  • Michael Krams
    President, Adaptive Trials and Clinical Development, Wyeth
  • Philip Lavori
    Chair, Stanford University Center for Health Research and Policy
  • Greg Lucier
    CEO, Invitrogen
  • Angela McNab
    Chief Executive, Human Fertilisation and Embryology Authority (HFEA, UK)
  • Steven Minger
    PhD., Director, Stem Cell Biology Laboratory, Wolfson Centre for Age-Related Diseases, King’s College London
  • Thomas Okarma
    President, CEO and Director, Geron Corporation
  • Mahendra Rao
    Vice President, Research, Stem Cells and Regenerative Medicine, Invitrogen Corporation
  • AnnaLee Saxsenian
    Dean, School of Information, University of California, Berkeley
  • Christopher Scott
    Executive Director, Stanford Program on Stem Cells and Society
  • Bernard Siegel
    President, Genetics Policy Institute
  • Debora Spar
    Senior Dean of Research, Harvard Business School
  • Susan Stayn
    Member, Stanford Program on Stem Cells in Society
  • Irving Weissman
    Director, Stanford University Institute for Regenerative Medicine
  • Dana Welch
    Executive Director, Berkeley Program on Law, Technology and Society
  • Michael Werner
    President, The Werner Group
  • Ian Wilmut
    University of Edinburgh
  • Kevin Wilson
    Director of Public Policy, American Society of Cell Biology
  • Celia Witten
    Director, Office of Cellular, Tissue, and Gene Therapy, Center for Biologics Evaluation and Research, FDA

    The registration cost is $1495 ($495 for academic and government registrants).

  • 781 total views, 1 views today

    © 2008-2015 The Prinz Law Office. All rights reserved.

    The Prinz Law Office | Silicon Valley, CA | Los Angeles, CA | Orange County, CA | San Diego, CA | Atlanta, GA | Tel: 1.800.884.2124

    Mailing Address: 117 Bernal Rd., Suite 70-110, San Jose, CA 95119; Silicon Valley Office: San Jose- 2033 Gateway Place, Suite 500, San Jose, CA 95110 (408)884-2854; Los Angeles Office: 3110 Main St., Building C, Santa Monica, CA 90405 (310)907-9218; Orange County Office: 100 Spectrum Center Drive, 9th Floor, Irvine, CA 92618 (949)236-6777; San Diego Office: 4455 Murphy Canyon Road, Suite 100, San Diego, CA 92123 (619)354-2727 Atlanta Office: 1000 Parkwood Circle, Suite 900, Atlanta, Georgia 30339 (404)479-2470

    Biotech Transactions Lawyer & Attorney: Serving Silicon Valley, San Jose, San Francisco, San Diego, Los Angeles, Orange County, Irvine, Anaheim, Santa Monica, Silicon Beach, Atlanta. Licensed in California and Georgia.

    Get every new post delivered to your Inbox

    Join other followers